Multimodality Imaging In Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles

• Jae Youn Hwang ,

  Contributed equally to this work with: Jae Youn Hwang, Jinhyoung Park

  * E-mail: hwangjy@cshs.org

  Affiliation Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Jinhyoung Park ,

  Contributed equally to this work with: Jae Youn Hwang, Jinhyoung Park

  Affiliation Department of Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Bong Jin Kang,

  Affiliation Department of Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America

  ⨯
• David J. Lubow,

  Affiliation Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• David Chu,

  Affiliation Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Daniel L. Farkas,

  Affiliations Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Department of Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America

  ⨯
• K. Kirk Shung,

  Affiliation Department of Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Lali K. Medina-Kauwe

  Affiliations Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Department of Medicine, University of California Los Angeles Geffen School of Medicine, Los Angeles, California, United States of America

  ⨯